Kore Private Wealth’s Guardant Health GH Stock Holding History

Kore Private Wealth’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-23	Closed	-$1K	–	577
2020 Q2	$1K	Buy	+23	New	+$1.85K	﹤0.01%	1097

Other funds holding GH

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Kore Private Wealth's GH Position: Q3 2020 in Review

Kore Private Wealth sold out of Guardant Health (GH) in Q3 2020, closing a stake of 23 shares — an estimated $1K sold.

Kore Private Wealth first reported a position in GH in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 346 funds tracked by Wall St. Rank hold GH as of Q3 2020.

Kore Private Wealth reported no remaining Guardant Health position as of Q3 2020 after selling out during the quarter.
Kore Private Wealth sold 23 Guardant Health shares in Q3 2020, an estimated $1K.
Kore Private Wealth first reported a position in Guardant Health in Q2 2020 and held it in 1 quarter.
Kore Private Wealth's Guardant Health position peaked at $1K in Q2 2020.
346 funds tracked by Wall St. Rank held Guardant Health as of Q3 2020.

Based on Kore Private Wealth's 13F filing for Q3 2020, filed 13 Nov 2020.